Life sciences executives are entering 2025 with data-driven optimism, according to Deloitte’s newly released “2025 Life Sciences Outlook.” Survey findings from 150 global C-suite executives show that 75% remain upbeat about the year ahead, with 68% anticipating revenue increases and 57% expecting margin expansions. Two key factors emerge from executive interviews: enhanced clarity following the…